LifeVantage (NASDAQ:LFVN – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 0.570-0.670 for the period, compared to the consensus earnings per share estimate of 0.600. The company issued revenue guidance of $202.0 million-$205.0 million, compared to the consensus revenue estimate of $209.3 million.
LifeVantage Price Performance
Shares of LFVN stock opened at $6.57 on Monday. The business’s fifty day moving average price is $6.51 and its 200 day moving average price is $6.37. LifeVantage has a 1-year low of $3.04 and a 1-year high of $8.69. The firm has a market capitalization of $83.44 million, a PE ratio of 23.46 and a beta of 0.80.
LifeVantage Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 31st will be issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 2.44%. This is an increase from LifeVantage’s previous quarterly dividend of $0.04. The ex-dividend date is Friday, May 31st. LifeVantage’s dividend payout ratio (DPR) is 50.00%.
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
See Also
- Five stocks we like better than LifeVantage
- Comparing and Trading High PE Ratio Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- EV Stocks and How to Profit from Them
- 3 Value Stocks You Can Buy Before They Become Big
- The 3 Best Fintech Stocks to Buy Now
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.
